VARIOUS REGIONS WITHIN THE ALPHA-HELICAL DOMAIN OF THE COL1A1 GENE ARE FUSED TO THE 2ND EXON OF THE PDGFB GENE IN DERMATOFIBROSARCOMAS AND GIANT-CELL FIBROBLASTOMAS
Kp. Obrien et al., VARIOUS REGIONS WITHIN THE ALPHA-HELICAL DOMAIN OF THE COL1A1 GENE ARE FUSED TO THE 2ND EXON OF THE PDGFB GENE IN DERMATOFIBROSARCOMAS AND GIANT-CELL FIBROBLASTOMAS, Genes, chromosomes & cancer, 23(2), 1998, pp. 187-193
Dermatofibrosarcoma protuberans (DFSP) and its juvenile form, giant-ce
ll fibroblastoma (GCF), are uncommon infiltrative tumors of the dermis
, which present unique cytogenetic features, such as the reciprocal tr
anslocation t(17;22) or, more commonly, supernumerary ring chromosomes
containing sequences from chromosomes 17 and 22. We have recently sho
wn that these aberrations are cytogenetic manifestations of gene fusio
ns between the platelet-derived growth factor B-chain gene (PDGFB), th
e cellular equivalent of the v-sis oncogene, and the collagen type I a
lpha I gene (COL1A1), the major protein constituent of the extracellul
ar matrix in connective tissue of skin. We now report characterization
of COL1A1/PDGFB chimeric genes at the RNA and DNA sequence levels in
a series of DFSPs and GCFs. All 16 tumors studied contained the COL1A1
/PDGFB gene. The location of breakpoints within COL1A1 varied greatly,
but was always limited to the region encoding the alpha-helical domai
n. The PDGFB segment of the chimeric transcript always starts with exo
n 2, placing PDGFB under the control of the COL1A1 promoter and removi
ng all known elements negatively controlling PDGFB transcription and t
ranslation. Production of these aberrant transcripts in fibroblasts, t
he suspected cell of origin of DFSP/GCF, likely causes autocrine stimu
lation and cell proliferation. No specific function has yet been assig
ned to exon 2 of PDGFB, and this exon does not encode for the mature g
rowth factor. Its retention in all chimeric COL1A1/PDGFB genes suggest
s that it is important for the normal processing of the PDGFB polypept
ide. (C) 1998 Wiley-Liss, Inc.